For thirty years, Biomed has developed innovative in-vitro diagnostic tools for clinicians around the globe. With new threats emerging in the form of HAIs – as well as the potential resurgence of AMR pathogens, our team stands ready to assist in your efforts to make the world a safer, healthier place.
Heathcare associated infections (HAIs), specifically hospital acquired nosociomal infections, pose a real threat to patient safety. InVitro diagnostic tests play a critical role with infection control, helping to substantially reduce HAI prevalence and associated costs. Reduce risk with Biomed's 3-in-1 InTray® products.